By Jenny Kemper, Director, Kemper Cognitive Wellness In the office at Kemper Cognitive Wellness, Dr. Bergman will marvel from time to time how much money people are willing to spend …
Published on Cleveland.com, July 2, 2021 By Shirley MacFarland, special to cleveland.com STRONGSVILLE, Ohio — Kemper House Residential Alzheimer’s and Dementia homes have cared for and supported Clevelanders impacted by dementia …
The Kemper House Family’s Focus is Prevention and Effective Treatment for Cognitive Loss Read More »
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman speaks with Dr. Marwan Sabbagh, clinical and research leader at the Cleveland Clinic’s Lou Ruvo Center for Brain Health. He …
Dr. Nate Bergman recently spoke with the folks at Wild Health Podcast. In this conversation, they discussed the difference between Alzheimer’s and dementia, the importance of starting interventions early, and …
Treating Alzheimer’s Disease with Dr. Nate Bergman- Wild Health Podcast Read More »
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman speaks with Doctors Ann Hathaway and Deborah Gordon, the two other physicians who led the ground-breaking clinical trial with Doctors …
People Getting Better- More Trial Results with Dr. Ann Hathaway & Dr. Deborah Gordon Read More »
It’s been 18 years since the last drug was approved for Alzheimer’s, but on Monday, June 7, 2021, the FDA gave “Accelerated Approval” to Biogen’s novel medication, Aducanumab (“Aduhelm”). The …
Aducanumab – Is this the end of Alzheimer’s? Not just yet… Read More »
The aging brain has an increased need for specific vitamins and minerals. In addition to correcting low micronutrient status, certain supplements have shown promise in improving cognitive function, memory, and …
The landscape is changing and it is possible to push back against cognitive decline! In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman chats with Dr. Kathleen Toups and …
New Study Results with Dr. Kathleen Toups & Dr. Dale Bredesen Read More »
Pharmaceutical trials for Alzheimer’s have failed repeatedly, but a new study, using a fundamentally different approach, has provided the first success: using precision medicine to identify and target the drivers …
In the News: Trial First to Show Improvements in Alzheimer’s Patients Read More »
